Encompass Health price target raised to $118 from $116 at Barclays

Barclays raised the firm’s price target on Encompass Health (EHC) to $118 from $116 and keeps an Overweight rating on the shares post the Q4 report. The company’s revenue and EBITDA guidance capture Street estimates and reinforce the strong underlying operating momentum in the business, the analyst tells investors in a research note.